The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | Exciting research in CTCL: genomics, the tumor microenvironment and the potential role of MRD
Pierluigi Porcu, MD, Jefferson Health, Sidney Kimmel Cancer Center, Philadelphia, PA, discusses ongoing research in the field of cutaneous T-cell lymphoma (CTCL). Dr Porcu highlights several interesting areas being explored, including genomic research using single-cell analysis, the tumor microenvironment, and studies exploring the potential role of measurable residual disease (MRD) as a strategy to redefine disease stage. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
